Zimmer Biomet Holdings Inc
Statements
Segments
US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of Zimmer Biomet Holdings Inc (ZBH). It shows which part of the business is growing — and which one is holding it back.
Revenue by product line
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Knees [Member] | $2.38B 38.8% | $2.65B 38.8% · +11.3% | $2.78B 40.0% · +4.9% | $3.04B 41.1% · +9.4% | $3.17B 41.3% · +4.4% | $3.32B 40.4% · +4.7% |
| S.E.T [Member] | $1.53B 24.9% | $1.73B 25.3% · +13.3% | $1.70B 24.4% · -1.8% | $1.75B 23.7% · +3.3% | $1.87B 24.3% · +6.5% | $2.15B 26.1% · +15.2% |
| Hips [Member] | $1.75B 28.6% | $1.86B 27.2% · +6.0% | $1.89B 27.3% · +2.1% | $1.97B 26.6% · +3.8% | $2.00B 26.0% · +1.6% | $2.09B 25.4% · +4.7% |
| Technology & Data, Bone Cement and Surgical [Member] | – | – | $570.0M 8.2% | $636.0M 8.6% · +11.6% | $640.3M 8.3% · +0.7% | $665.6M 8.1% · +4.0% |
| Other [Member] | $473.1M 7.7% | $595.5M 8.7% · +25.9% | – | – | – | – |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.
Data as of: August 10, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.